RD532 - Substance Abuse Services Council Report on Treatment Programs for FY 2020 – December 1, 2020 – revised on March 16, 2021
*This report was replaced in its entirety by the Substance Abuse Services Council on March 16, 2021.
This report summarizes information from the four executive branch agencies that provide substance use disorder treatment services: The Department of Behavioral Health and Developmental Services (DBHDS), the Department of Juvenile Justice (DJJ), the Department of Corrections (DOC) and the Department of Medical Assistance Services (DMAS). These agencies share the common goals of increasing the health and wellness of Virginia’s individuals, families, and communities, increasing access to substance use disorder treatment and recovery services, and reducing the impact of those with a substance use disorder and involvement in the criminal justice system. All of the agencies included in this report are invested in providing evidenced-based treatment and recovery services to their populations within the specific constraints each has on its ability to provide these services. In this report, the following information is detailed concerning each of these four agencies’ substance use disorder treatment programs:
1. Amount of funding spent for the program in FY 2020;
As used in this document, treatment means those services directed toward individuals with identified substance use disorders and does not include prevention services. This report provides information for Fiscal Year 2020, which covers the period from July 1, 2019 through June 30, 2020.
Treatment Programs for FY 2020
This report provides focused data on specific outcomes. Every opioid overdose death represents many affected individuals (see Figure 1), and every individual who commits a crime associated with substance misuse represents many others who are also involved. Many of these individuals are struggling with functional impairment and this is reflected in decreased workforce participation,(*1) negative impact on the economy,(*2) the potential for dissemination of blood borne diseases,(*3) and recidivism.
While we are thankful for the inclusion of Methamphetamine treatment in the monies allocated for 2020, it should be noted that singling out specific substances such as opioids, methamphetamines, or other “unfunded" substances, fails to recognize substance use disorder as being non-substance specific. In turn, this leads to “chasing" one drug or another similar to squeezing a balloon – if it gets small on one end, it will get bigger on the other. This results in duplicated services, wasted money, and poor outcomes.